respimmun.at

Welcome

Description

Faculty

Young Faculty

• Avian
• Bärnthaler
• Biasin
• Birnhuber
• Brčić
• Crnković
• Douschan
• Foris
• Jandl
• Kovács
• Lindenmann
Nagaraj ⏩
• Vesely

Students

Training

Publications

PhD Program
Congress (Retreat)

 

• Webmaster

The RESPImmun Young Faculty

Chandran NAGARAJ, PhD

Otto Loewi Research Center, Division of Physiology; Medical University of Graz, Ludwig Boltzmann Institute for Lung and Vascular Research, Neue Stiftingstalstraße 6/VI, A-8010 Graz;
phone: +43-316-385 72918, fax: +43-316-385 79005,  e-mail
websites: [RESPImmun] [LBI]
• Profile     • Curriculum vitae     • PhD students     • Grants     • Publications ⏬    

List of publications:

10 most significant publications:

  1. Papp R, Nagaraj C, Zabini D, Nagy BM, Lengyel M, Skofic Maurer D, Sharma N, Egemnazarov B, Kovacs G, Kwapiszewska G, Marsh LM, Hrzenjak A, Höfler G, Didiasova M, Wygrecka M, Sievers LK, Szucs P, Enyedi P, Ghanim B, Klepetko W, Olschewski H, Olschewski A: Targeting TMEM16A to reverse vasoconstriction and remodelling in idiopathic pulmonary arterial hypertension. Eur Respir J, 2019; 53(6):​1800965.
  2. Mohan T, Nagaraj C, Nagy BM, Bračič M, Maver U, Olschewski A, Stana Kleinschek K, Kargl R: Nano- and Micropatterned Polycaprolactone Cellulose Composite Surfaces with Tunable Protein Adsorption, Fibrin Clot Formation, and Endothelial Cellular Response. Biomacromolecules, 2019; 20(6):​2327–2337.
  3. Fazakas C, Nagaraj C, Zabini D, Végh AG, Marsh LM, Wilhelm I, Krizbai IA, Olschewski H, Olschewski A, Bálint Z: Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension. Front Physiol, 2018; 9:​537.
  4. Nagaraj C, Tabeling C, Nagy BM, Jain PP, Marsh LM, Papp R, Pienn M, Witzenrath M, Ghanim B, Klepetko W, Weir EK, Heschl S, Kwapiszewska G, Olschewski A, Olschewski H: Hypoxic vascular response and ventilation/perfusion matching in end-stage COPD may depend on p22phox. Eur Respir J, 2017; 50(1):​1601651.
  5. Nagy BM, Nagaraj C, Meinitzer A, Sharma N, Papp R, Foris V, Ghanim B, Kwapiszewska G, Kovacs G, Klepetko W, Pieber TR, Mangge H, Olschewski H, Olschewski A: Importance of kynurenine in pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol, 2017; 313(5):​L741–L751.
  6. Nagaraj C, Haitchi HM, Heinemann A, Howarth PH, Olschewski A, Marsh LM: Increased Expression of p22phox Mediates Airway Hyperresponsiveness in an Experimental Model of Asthma. Antioxid Redox Signal, 2017; 27(18):​1460–1472.
  7. Nagy BM, Nagaraj C, Egemnazarov B, Kwapiszewska G, Stauber RE, Avian A, Olschewski H, Olschewski A: Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia. Front Physiol, 2017; 8:98.
  8. Nagaraj C, Tang B, Nagy BM, Papp R, Jain PP, Marsh LM, Meredith AL, Ghanim B, Klepetko W, Kwapiszewska G, Weir EK, Olschewski H, Olschewski A: Docosahexaenoic acid causes rapid pulmonary arterial relaxation via KCa channel-mediated hyperpolarisation in pulmonary hypertension. Eur Respir J, 2016; 48(4):​1127–1136.
  9. Nagaraj C, Tang B, Bálint Z, Wygrecka M, Hrzenjak A, Kwapiszewska G, Stacher E, Lindenmann J, Weir EK, Olschewski H, Olschewski A.: Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries. Eur Respir J, 2013; 41(1):​85–95.
  10. Li Y, Connolly M, Nagaraj C, Tang B, Bálint Z, Popper H, Smolle-Juettner FM, Lindenmann J, Kwapiszewska G, Aaronson PI, Wohlkoenig C, Leithner K, Olschewski H, Olschewski A: Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation. Am J Respir Cell Mol Biol, 2012; 46(3):​372–379.